Mr. Maddox focuses on patent litigation in life sciences technology, with special expertise in pharmaceutical Hatch Waxman cases and medical devices.
Mr. Maddox has been recognized as a life sciences star for his litigation practice in LMG Life Sciences, published by Managing Intellectual Property.
He has received special recognition for his work in generic drugs, biosimilars, drug formulations, large molecules and vaccines.
Prior to entering private practice, Mr. Maddox served as a trial attorney at the United States Department of Justice.
He clerked for The Honorable Thomas P. Griesa, former Chief Judge of the United States District Court for the Southern District of New York.
- J.D., University of Virginia School of Law (Order of the Coif), 1989
- A.B., Harvard University, Economics and History (magna cum laude), 1986
- District of Columbia
- U.S. Court of Appeals for the Federal Circuit
- U.S. Supreme Court
Seminars and Presentations
- Panelist, “The Master Class on Settling Paragraph IV Disputes: Drafting and Negotiating Strategies for Brand-Names and Generic – A Hands-On, Practical Approach,” American Conference Institute (ACI) Paragraph IV Disputes Conference, 2012
- Panelist, “Invalid or Will Not Be Infringed”: Re-Assessing the ANDA Applicant’s Pre-Litigation Considerations and Obligations Under Paragraph IV vis-à-vis Microsoft v. i4i, American Conference Institute (ACI) Paragraph IV Disputes Conference, 2011
- Co-author, Trial in ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators, American Bar Association (Section of Intellectual Property Law), 2020